Navigation Links
Guidelines help patients reduce risk of cardiac event before surgery
Date:9/27/2007

People with heart disease should take special precautions before undergoing any kind of surgery, even noncardiac surgery, to reduce their risk of a cardiac event, according to new joint guidelines from the American College of Cardiology and the American Heart Association.

The American College of Cardiology/American Heart Association 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery will be published online ahead of print on September 27 in the October 23, 2007, issues of Circulation: Journal of the American Heart Association and the Journal of the American College of Cardiology.

The guidelines an update of those published in 2002 provide a framework for considering a persons risk of a cardiac event in the perioperative (during or immediately after) period of noncardiac surgery.

According to the recommendations, patients should not stop taking cholesterol-lowering drugs before surgery. In addition, the guidelines say that many people with heart disease can safely undergo noncardiac surgery without first fixing their heart disease with an artery-opening procedure or coronary bypass grafting. The guidelines also address how best to treat those people who need a heart procedure before noncardiac surgery, have coronary stents or require anti-clotting medication.

In the past we had to go on indefinite evidence, but now there are a number of studies published to help us direct best practices, said Lee A. Fleisher, M.D., chair of the guideline writing committee. Statin use wasnt even addressed in the previous guidelines. New trials have shown us that patients should continue taking them.

In the case of non-emergency or elective procedures, the guidelines say that intervention (such as bypass surgery or angioplasty) is rarely necessary to lower the risk of surgery unless a patient would need the intervention anyway. If the noncardiac surgery is an emergency, heart testing should be forgone and a
'/>"/>

Contact: Cathy Lewis
cathy.lewis@heart.org
214-706-1324
American Heart Association
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related medicine news :

1. New CPR Guidelines issued by Heart Association
2. New guidelines for dealing with post traumatic stress disorder
3. New Guidelines Found To Benefit Cardiovascular Treatment
4. Healthy Feeding Guidelines for Children Ages 0 to 24 Months Issued
5. Fragile X-Associated Tremor /Ataxia Syndrome Need Guidelines For Diagnostic Tests
6. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
7. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
8. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
9. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
10. Guidelines for treatment of juvenile idiopathic arthritis formulated
11. Guidelines For Better Management Of Obsessive-Compulsive Disorder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., DALLAS,Nov.27/PRNewswire-USNewswire/--Conside...y25yearsago,solidorgantransplantationisnowalife-sa...andwomenwhogatheredattheWinspearOperaHouseinDallas...ndtheworldtocelebratethe25thanniversaryofBaylorReg...olidorgantransplantintheUnitedStates. ,, Itwas2...
(Date:11/27/2009)... , ROCHESTER, N.Y., Nov. 27 /PRNewswire-USNe... health care provider and fortunately every year, ...prevention. But do all vaccines boost immunity for...ditional ,booster shots, needed to keep immunity s..., the Journal of the American Academy of Pediatric...
(Date:11/27/2009)... , KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswir...aq: SHMR ) ( "Shamir" ), a leading provider of in... lens market, announced today that its board of di... aggregate amount of US$ 10 million (approximately...representative rate of exchange), or approximately...
(Date:11/27/2009)...king and cycling plus low-emission vehicles may re... , FRIDAY, Nov. 27 (HealthDay News) -- Encour... using cars would offer much greater public health...cles, U.K. researchers have found. , The study ...lternative urban land transport scenarios for Lond...
(Date:11/27/2009)..., SEATTLE,Nov.27/PRNewswire/-- Allrecipes.com ...vingtrafficnumbers,withmorethan2.8millionvisitorst...atwasservedonthebiggestfoodholidayoftheyear.Theave...perserving,a5percentincreasefromlastyear,sfeast.Ac...heshowasthemostpopularThanksgivingrecipe,acontrast...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3
...bivalirudin (Angiomax) that beats the standard com...nary syndromes such as heart// attacks. This new b...uffering from acute coronary syndromes. The ...nal of Medicine. The Medicines Company and Nycome...
... in a Farm in South Korea, killing around 6,000 ch... more, South Korea’s Farm// Ministry officials sai...ference, Kim Chang-sub, a top official at the Mini...s of our testing should be known on 25th of Novemb...
...e sale of turbot after they detected high levels o...ing’s fish markets, reports the Chinese media. The...pe in 1992. Due to low resistance to disease...n, Liaoning and Xi'an have started inspections aft...
...s grouped the five major cities Vancouver//, Calga...ods, based on five features namely income, educa...one-parent families. It also observes neighb...streets, public transportation, and how well peopl...
...ert with sophisticated transgenic technologies, //...rst time created three-dimensional, time-lapse mov... live tumor tissues. In recorded experiments, immu...his new view of the body’s on-board defenses again...
... had to be hospitalized following cosmetic injecti...an cosmetic product that was unlicensed. The injec...es greater than the lethal dose for humans, report...ogists. Four persons including a doctor had to ...
Other Medicine News:Health News:New Anti-Clotting Drug Less Risky For Heart Attack Patients 2Health News:Health Of Residents Is Affected by Various Factors 2Health News:Innovative Movies Show Real-Time Immune-Cell Activity within Tumors 2Health News:Innovative Movies Show Real-Time Immune-Cell Activity within Tumors 3
(Date:11/27/2009)...TON, Minn, Nov. 27 ACUO TECHNOLOGI...anagement software, data migration tools and servi... Patent and Trademark Office has approved a patent...thin a Computer Network." Acuo Technologies is ple...tellectual property. In general, the granted paten...
(Date:11/25/2009)...A PARK, Calif., Nov. 25 Praxis Ele...ngs in the American Academy of Family Physicians, ...ser Satisfaction Survey for improving medical qual...ll critical for new ARRA Stimulus legislation. Pra...EMR had a positive effect in determining their sal...
(Date:11/25/2009)...ORD, Mass., Nov. 25 Holo...), a leading developer, manufacturer and supplier ...d surgical products dedicated to serving the healt...of the Radiological Society of North America (RSNA...gh December 3, 2009 to highlight our new SecurView...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Drug Combo May Offer Best Relief for Nerve Pain 58527 1Drug Combo May Offer Best Relief for Nerve Pain 58527 2Australian study sheds light on kidney repair and disease 10181 1Australian study sheds light on kidney repair and disease 10181 2Cardinal Health Foundation Invites Health Care Providers to Apply for 241 Million in Grants to Improve Efficiency Quality of Care 58524 1Cardinal Health Foundation Invites Health Care Providers to Apply for 241 Million in Grants to Improve Efficiency Quality of Care 58524 2
...ee large PEGINTRON(TM) clinical studies address ke...OPENHAGEN, Denmark, April 27 Schering-Plough Corp...esults of three large PEGINTRON(TM) (peginterferon...estions in the hepatitis C research community and ...udies, involving a total of more than 2,700 patien...
...s $10 million milestone payment to Pharmasset , ,...aq: VRUS ) and Roche (Roche SWX: RO, ROG; Pink S...nt has been dosed in a Phase IIb study of R7128, t...n development for the treatment of chronic hepatit...uration of treatment of R7128 in combination with ...
Other Medicine Technology:Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 2Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 3Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 4Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 5Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 6Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 7Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 8Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 9Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 10Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting 11Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 2Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 3Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 4Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 5Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 6Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 7Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 8Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 9Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 10
ENDOlap™ 25 liter Heated Insufflator
Insufflators
KLEPPINGER bipolar forceps
...thologist to visualize the presence of Human Papil... choice of sample types: tissue, monolayer-based p...ocktails utilize proprietary probe formulations. T... genotypes 16, 18, 31, 33, 35, 39, 51, 52, 56, 58,...
Medicine Products: